ZA869333B - Heteroaromatic acetylenes useful as antihypertensive agents - Google Patents
Heteroaromatic acetylenes useful as antihypertensive agentsInfo
- Publication number
- ZA869333B ZA869333B ZA869333A ZA869333A ZA869333B ZA 869333 B ZA869333 B ZA 869333B ZA 869333 A ZA869333 A ZA 869333A ZA 869333 A ZA869333 A ZA 869333A ZA 869333 B ZA869333 B ZA 869333B
- Authority
- ZA
- South Africa
- Prior art keywords
- acetylenes
- heteroaromatic
- useful
- antihypertensive agents
- antihypertensive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/807,551 US4663334A (en) | 1985-12-11 | 1985-12-11 | Heteroaromatic acetylenes useful as antihypertensive agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA869333B true ZA869333B (en) | 1988-07-27 |
Family
ID=25196656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA869333A ZA869333B (en) | 1985-12-11 | 1986-12-10 | Heteroaromatic acetylenes useful as antihypertensive agents |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4663334A (xx) |
| EP (1) | EP0226447A3 (xx) |
| JP (1) | JPS62175460A (xx) |
| KR (1) | KR870005996A (xx) |
| CN (1) | CN86108922A (xx) |
| AU (1) | AU597319B2 (xx) |
| CA (1) | CA1292739C (xx) |
| DK (1) | DK594686A (xx) |
| FI (1) | FI865028A (xx) |
| HU (1) | HU196373B (xx) |
| NO (1) | NO864987L (xx) |
| NZ (1) | NZ218441A (xx) |
| ZA (1) | ZA869333B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264456A (en) * | 1989-12-29 | 1993-11-23 | Allergan, Inc. | Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity |
| SE9103397D0 (sv) * | 1991-11-18 | 1991-11-18 | Kabi Pharmacia Ab | Nya substituerade salicylsyror |
| EP1303495B1 (en) * | 2000-07-24 | 2010-05-26 | Krenitsky Pharmaceuticals, Inc. | Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| US7452911B2 (en) * | 2002-10-31 | 2008-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| CN105541769A (zh) * | 2007-06-29 | 2016-05-04 | 奥克塞拉有限公司 | 用于治疗眼科疾病和紊乱的炔基苯基衍生化合物 |
| CN109793733B (zh) * | 2019-03-28 | 2021-11-12 | 四川大学 | 3-氨基-5-炔基吡唑类化合物作为fgfr抑制剂 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6600177A (xx) * | 1966-01-07 | 1967-07-10 | ||
| US4010158A (en) * | 1967-05-18 | 1977-03-01 | Boehringer Ingelheim Gmbh | 1-(2'-Ethynyl-phenoxy)-2-hydroxy-3-butylamino-propanes and salts |
| US3914432A (en) * | 1967-12-13 | 1975-10-21 | Boehringer Sohn Ingelheim | Pharmaceutical compositions containing a 1-(cyano-phenoxy)-2-hydroxy-3-alkylamino-propane and method of use |
| US3959338A (en) * | 1970-10-05 | 1976-05-25 | Boehringer Ingelheim Gmbh | 1-(Cyano-phenoxy)-2-hydroxy-3-hydroxyalkylamino-propanes and salts thereof |
| DE2503222A1 (de) * | 1975-01-27 | 1976-07-29 | Boehringer Sohn Ingelheim | Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten |
| DE3006351A1 (de) * | 1980-02-20 | 1981-09-17 | Basf Ag, 6700 Ludwigshafen | 2- ((3-amino-2- hydroxy-propoxy)-styryl )-verbindungen |
| US4412856A (en) * | 1980-05-31 | 1983-11-01 | Ciba-Geigy Corporation | Herbicidal heterocyclic and substituted phenyl phenylacetylene amines |
| KR850004095A (ko) * | 1983-11-21 | 1985-07-01 | 에취. 아이. 쉐르만 | 아세틸렌 유도체의 제조방법 |
| FR2558158B1 (fr) * | 1984-01-13 | 1986-05-16 | Roussel Uclaf | Derives de l'indole ethenyl phenol, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et intermediaires |
| US4652584A (en) * | 1984-07-13 | 1987-03-24 | Mcneilab, Inc. | Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension |
-
1985
- 1985-12-11 US US06/807,551 patent/US4663334A/en not_active Expired - Lifetime
-
1986
- 1986-11-28 NZ NZ218441A patent/NZ218441A/xx unknown
- 1986-12-09 CA CA000524856A patent/CA1292739C/en not_active Expired - Lifetime
- 1986-12-10 ZA ZA869333A patent/ZA869333B/xx unknown
- 1986-12-10 NO NO864987A patent/NO864987L/no unknown
- 1986-12-10 FI FI865028A patent/FI865028A/fi not_active Application Discontinuation
- 1986-12-10 DK DK594686A patent/DK594686A/da not_active Application Discontinuation
- 1986-12-10 EP EP86309601A patent/EP0226447A3/en not_active Withdrawn
- 1986-12-10 JP JP61292673A patent/JPS62175460A/ja active Pending
- 1986-12-11 AU AU66424/86A patent/AU597319B2/en not_active Ceased
- 1986-12-11 HU HU865174A patent/HU196373B/hu unknown
- 1986-12-11 CN CN198686108922A patent/CN86108922A/zh active Pending
- 1986-12-11 KR KR860010583A patent/KR870005996A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI865028A0 (fi) | 1986-12-10 |
| US4663334A (en) | 1987-05-05 |
| EP0226447A2 (en) | 1987-06-24 |
| JPS62175460A (ja) | 1987-08-01 |
| AU6642486A (en) | 1988-06-16 |
| EP0226447A3 (en) | 1988-08-31 |
| DK594686D0 (da) | 1986-12-10 |
| NZ218441A (en) | 1989-04-26 |
| FI865028A (fi) | 1987-06-12 |
| HU196373B (en) | 1988-11-28 |
| CA1292739C (en) | 1991-12-03 |
| KR870005996A (ko) | 1987-07-08 |
| HUT44013A (en) | 1988-01-28 |
| AU597319B2 (en) | 1990-05-31 |
| CN86108922A (zh) | 1987-08-05 |
| NO864987D0 (no) | 1986-12-10 |
| NO864987L (no) | 1987-06-12 |
| DK594686A (da) | 1987-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3662290D1 (en) | Composition for oriented drilling | |
| GB8621580D0 (en) | Composition | |
| GB8531635D0 (en) | Composition | |
| GB2179338B (en) | Composition | |
| GR861462B (en) | Microemulsion compositions | |
| GB8514855D0 (en) | Galenic retard form | |
| GB8508717D0 (en) | Composition | |
| GB8500862D0 (en) | Composition | |
| GB8622856D0 (en) | Composition | |
| GB8629991D0 (en) | Fat-desensitizing composition | |
| NZ230711A (en) | Substituted thienopyrans as antihypertensive agents | |
| GB8614989D0 (en) | Parasiticidal composition | |
| ZA869333B (en) | Heteroaromatic acetylenes useful as antihypertensive agents | |
| GB8506174D0 (en) | 4-amino-6 7-dimethoxy-2-piperazin-1-ylquinazoline derivatives | |
| GB8604135D0 (en) | Composition | |
| EP0192630A3 (en) | Aminomethylenephosphonate compositions | |
| ZA865426B (en) | Antihypertensive agents | |
| ZA856886B (en) | Antihypertensive derivatives | |
| GB8618196D0 (en) | Antihypertensive agents | |
| GB8514418D0 (en) | Aminobenzylamine composition | |
| PT83574A (en) | Composition | |
| EP0225309A3 (en) | Aminomethylenephosphonate compositions | |
| GR861916B (en) | Antihypertensive agents | |
| GB2155015B (en) | Antihypertensive spiro-amidoamino compounds | |
| ZA897253B (en) | Novel substituted thienopyrans as antihypertensive agents |